We are live on ! Find out more
TDC

Thompson Davis & Co Portfolio holdings

AUM $150M
1-Year Est. Return 32.35%
This Fund
S&P 500
This Quarter Est. Return
+11.83%
1 Year Est. Return
+32.35%
3 Year Est. Return
+199.51%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$42.2M
AUM Growth
-$14.3M
Cap. Flow
-$17.4M
Cap. Flow %
-41.13%
Top 10 Hldgs %
21.94%
Holding
1,277
New
146
Increased
131
Reduced
218
Closed
593

Top Buys

Rank Stock Value
1
VBR icon
Vanguard Small-Cap Value ETF
VBR
+$601K
2
KNSL icon
Kinsale Capital Group
KNSL
+$335K
3
PXLW icon
Pixelworks
PXLW
+$273K
4
GM icon
General Motors
GM
+$255K
5
MITL
Mitel Networks Corporation
MITL
+$250K

Top Sells

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$623K
2
INTC icon
Intel
INTC
+$608K
3
BAC icon
Bank of America
BAC
+$558K
4
AAPL icon
Apple
AAPL
+$527K
5
FDC
First Data Corporation
FDC
+$384K

Sector Composition

Rank Sector Weight
1 Technology 18.91%
2 Financials 9.93%
3 Healthcare 9.91%
4 Industrials 9.33%
5 Consumer Discretionary 7.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KNDI
576
Kandi Technologies Group
KNDI
$65.3M
$3K 0.01%
500
– –
LUMN icon
577
Lumen
LUMN
$6.53B
$3K 0.01%
200
– –
NLY icon
578
Annaly Capital Management
NLY
$16.9B
$3K 0.01%
63
+32
+103% +$1.52K
PSEC icon
579
Prospect Capital
PSEC
$1.06B
$3K 0.01%
+500
New +$3.26K
PUMP icon
580
ProPetro Holding
PUMP
$1.45B
$3K 0.01%
125
– –
AIXC
581
AIxCrypto Holdings Inc
AIXC
$16.6M
– –
0
– –
RDNT icon
582
RadNet
RDNT
$4.84B
$3K 0.01%
250
-1,000
-80% -$10.4K
REI icon
583
Ring Energy
REI
$322M
$3K 0.01%
250
– –
SGRY icon
584
Surgery Partners
SGRY
$2.06B
$3K 0.01%
250
-750
-75% -$7.17K
SONN
585
DELISTED
Sonnet BioTherapeutics
SONN
– –
0
– –
VCEL icon
586
Vericel Corp
VCEL
$2.3B
$3K 0.01%
+500
New +$2.31K
WBD icon
587
Warner Bros
WBD
$64.6B
$3K 0.01%
125
-78
-38% -$1.52K
ZBH icon
588
Zimmer Biomet
ZBH
$17.7B
$3K 0.01%
26
– –
CNSL
589
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
$3K 0.01%
250
-1,288
-84% -$20.2K
EXPR
590
DELISTED
Express, Inc.
EXPR
$3K 0.01%
+13
New +$2.13K
PTE
591
DELISTED
PolarityTE, Inc. Common Stock
PTE
$3K 0.01%
5
– –
FMI
592
DELISTED
Foundation Medicine, Inc.
FMI
$3K 0.01%
+50
New +$2.59K
IXYS
593
DELISTED
IXYS Corp
IXYS
$3K 0.01%
125
– –
HYGS
594
DELISTED
Hydrogenics Corp
HYGS
$3K 0.01%
+250
New +$2.48K
GCI
595
DELISTED
Gannett Co., Inc
GCI
$3K 0.01%
+250
New +$2.61K
ATRA icon
596
Atara Biotherapeutics
ATRA
$71.2M
$2K ﹤0.01%
+5
New +$1.85K
CC icon
597
Chemours
CC
$2.59B
$2K ﹤0.01%
40
– –
CHI
598
Calamos Convertible Opportunities and Income Fund
CHI
$1.02B
$2K ﹤0.01%
162
– –
CHRD icon
599
Chord Energy
CHRD
$7.79B
$2K ﹤0.01%
250
– –
FLNT
600
Fluent
FLNT
$102M
$2K ﹤0.01%
83
-667
-89% -$17.8K
22 23
24
25 26

Similar funds

PAYA
Phil A. Younker & Associates Fairbanks, Alaska $150M AUM 9.85% 1-Year Est. Return
PCMNC
Piedmont Capital Management (North Carolina) Greensboro, North Carolina $150M AUM
LA
Lakeside Advisors Seattle, Washington $150M AUM 14.73% 1-Year Est. Return
MPW
Magnolia Private Wealth Philadelphia, Pennsylvania $150M AUM 18.29% 1-Year Est. Return
GWA
Genesis Wealth Advisors Braintree, Massachusetts $150M AUM 15.35% 1-Year Est. Return
GA
Gordian Advisors Tucson, Arizona $150M AUM 15.35% 1-Year Est. Return
RPA
Redwood Park Advisors Redwood City, California $150M AUM 11.34% 1-Year Est. Return
E
Evansbrook Bolingbrook, Illinois $150M AUM

Thompson Davis & Co's Q4 2017 Portfolio in Review

As of Q4 2017, Thompson Davis & Co held 1,277 positions worth $42.2M, down 25% from $56.5M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Thompson Davis & Co withdrew a net $17.4M in Q4 2017, closing 593 positions and reducing 218 holdings. Its most notable exit was Antares Pharma, Inc., an estimated $365K position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Thompson Davis & Co opened a new position in General Motors worth $241K.

  • Thompson Davis & Co's largest Q4 2017 buy was General Motors: 5,878 shares worth $241K.
  • Thompson Davis & Co added most to Vanguard Small-Cap Value ETF in Q4 2017, an estimated $601K increase.
  • Thompson Davis & Co's biggest Q4 2017 reduction was JPMorgan Chase, cutting an estimated $623K.
  • Thompson Davis & Co fully exited Antares Pharma, Inc. in Q4 2017, selling an estimated $365K.
  • Thompson Davis & Co's ten largest holdings make up 22% of its $42.2M portfolio in Q4 2017.
  • Thompson Davis & Co opened 146 new positions and closed 593 in Q4 2017.
  • Thompson Davis & Co's portfolio value fell 25% quarter-over-quarter to $42.2M.

Based on Thompson Davis & Co's 13F filing for Q4 2017, filed 5 Feb 2018.